VA-118020

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameVA-118020
Drug Alias Namekallikrein 1 inhibitor (Vantia)KKIVA-118020FE-999155
ClassificationSmall molecules
Mechanisms of ActionKallikrein-1 inhibitors
TargetsKallikrein-1
Therapy Area/IndicationsRespiratory Tract Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVantia Therapeutics Ltd.
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVantia Therapeutics Ltd.
Active IndicationsN/A
Inactive IndicationsRespiratory Tract Diseases

Other Information

ATC CodeN/A
Related LinksN/A